GW-TT2: Achieving Reliable Nasal Delivery of Hydrophobic Drugs Through Formulation–Device Alignment

• Explore the impact of various formulation attributes on CNS and inner ear targeting
• Understand challenges in low-dose delivery and strategies to prevent underdosing
• Case study examples from a unique nasal formulation and delivery relief to recent onset tinnitus

Speakers:

Jianxin Bao

Co-Founder and Chief Executive Officer

Gateway Biotechnology Inc.